Likewise, in a recent study of a large number of patients at risk of type 2 diabetes, repeated sCD163 measurements correlated with HOMA‐IR and were predictive of incident dysglycemia (Semnani‐Azad et al., 2020). This evidence concerns the gene CD163 and type 2 diabetes mellitus.